Business Context and Reporting Period
This Form 8-K is filed by CF Finance Acquisition Corp. III ("CF III") on July 21, 2021. The filing reports on the proposed business combination between CF III and AEye, Inc. ("AEye"). Under the Merger Agreement, a subsidiary of CF III will merge with AEye, resulting in AEye becoming a wholly-owned subsidiary of CF III.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain audited financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics for either CF III or AEye. The filing text does not provide a clear value for these financial indicators.
Material Changes and Transaction Status
- SEC Approval: The Securities and Exchange Commission has declared effective the registration statement on Form S-4 filed in connection with the merger transactions.
- Shareholder Meeting: A special meeting of CF III stockholders is scheduled for Thursday, August 12, 2021, at 9:30 a.m. Eastern Time to vote on proposals related to the merger.
- Transaction Structure: The merger involves CF III, its subsidiary Meliora Merger Sub, Inc., and AEye, Inc., with AEye surviving as a subsidiary of CF III.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the expectations and strategies of both companies but explicitly states that neither company gives assurance that expectations will be achieved. Investors are cautioned that actual results may differ materially due to risks and uncertainties detailed in the Form S-1 and the definitive proxy statement/prospectus on Form S-4. The document includes standard non-solicitation language, clarifying that this 8-K is not an offer to sell securities.
Investor Verification Checklist
- Verify the final vote results of the special stockholder meeting scheduled for August 12, 2021.
- Review the definitive proxy statement/prospectus (Form S-4) for detailed risk factors and transaction terms.
- Confirm the post-merger capital structure and the treatment of CF III's units, common stock, and warrants.
- Monitor for any regulatory conditions or delays that could impact the closing of the merger.